Vagulienė, N. 2022. ATEZOLIZUMAB FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER: UPDATED OVERALL SURVIVAL ANALYSIS FROM IMPOWER110. Pulmonology and allergology. 6, 1 (Jun. 2022), 91-96. DOI:https://doi.org/10.37499/PIA.972.